Clostridium Difficile Colitis: What Is New? (T)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Trauma.
This Panel Session will address the diagnosis of Clostridium difficile (C. difficile) colitis and various treatment options for C. difficile colitis including the use of vancomycin/flagyl, vancomycin enemas, diverting ileostomy, subtotal colectomy with end ileostomy, and fecal transplant. Treatment plans for recurrent and recalcitrant C. difficile colitis will also be addressed. Fecal transplant is a very promising treatment option for C. difficile colitis, with excellent reported results; however, the use of fecal transplant is very infrequent. This panel will identify when a fecal transplant should be considered as the treatment of choice, methods of fecal transplant, and recommendations for the development of a fecal transplant program.
Clarence E. Clark, MD, FACS, Atlanta, GA
- Clostridium Difficile Colitis: Risk Factors, Diagnosis, and Prevention
Konstantin Umanskiy, MD, FACS, Chicago, IL
- Acute Clostridium Difficile Colitis: Is Colectomy Ever Indicated?
Sook C. Hoang, MD, Charlottesville, VA
- The Scoop on Poop: Fecal Transplantation in the Treatment of Clostridium Difficile Colitis
Jessica R. Allegretti, MD, Boston, MA
Amy Halverson, MD, FACS, FASCRS,Chicago, IL
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Clarence E. Clark, MD, FACS, Atlanta, GA - No Disclosures
Konstantin Umanskiy, MD, FACS, Chicago, IL -Applied Medical: Compensation: Speaker
Sook C. Hoang, MD, Charlottesville, VA - No Disclosures
Jessica R. Allegretti, MD, Boston, MA -Finch therapeutics : Consulting Fee: Research support/ consulting
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit